Full-Time

GPCR Molecular Pharmacologist

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for biopharmaceutical research

Government & Public Sector
Enterprise Software
Biotechnology

Compensation Overview

$120k - $160kAnnually

Mid

San Diego, CA, USA

Category
Computational Biology
Biology Lab & Research
Biology & Biotech

You match the following Schrödinger's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • PhD in molecular pharmacology with one to three years of experience in pharmaceutical or biotechnology industries (though we'll consider applicants with two-year postdoctoral work focused on GPCRs)
  • In-depth knowledge of the intricacies of multiple signaling pathways, biased signaling, and internalization/recycling of GPCRs
  • Background in in vitro biology assay development and execution as it relates to screening funnels for drug discovery programs
  • Experience in cell-based techniques such as HTRF, NanoBRET, Tag-Lite, and Label-Free technologies (kinetic and endpoint modes)
Responsibilities
  • Guide in vitro biology strategies for exploratory and early-stage drug discovery efforts
  • Manage experimental design, development, and implementation of cell-based assays for small molecule drug discovery projects
  • Independently train and manage CRO scientists for in vitro biology assay development and compound screening efforts
  • Oversee review, analysis, and interpretation of in vitro data
  • Collaborate with other functional area experts on hit-finding activities in the undrugged target space
Desired Qualifications
  • Know-how and perseverance in cracking and interrogating orphan GPCR pharmacology is preferred
  • Experience managing external studies at CROs is preferred

Schrödinger provides a computational platform that aids in the research and development efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and research across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the drug development process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative research and drug discovery programs, allowing them to work closely with clients to tailor solutions to their specific needs. The company's goal is to enhance scientific research and innovation by providing powerful computational resources that can lead to the discovery of new drugs and therapies.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Simplify Jobs

Simplify's Take

What believers are saying

  • $19.5M Gates Foundation grant boosts platform for neglected diseases, expanding market reach.
  • Predictive toxicology tools initiative could lead to safer, efficient drug development.
  • SGR-1505 discovery showcases ability to reduce drug discovery timelines significantly.

What critics are saying

  • Recursion and Exscientia merger creates strong AI-driven drug discovery competitor.
  • Avicenna's independent expansion could lead to competitive tensions with Schrödinger.
  • High R&D costs may strain resources despite Gates Foundation's $10M grant.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharma, academia, and government labs.
  • The company excels in rapid drug discovery, exemplified by SGR-1505's swift development.
  • Schrödinger's collaboration with Avicenna enhances medicinal chemistry through machine learning.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Parental Leave